UA108596C2 - Інгібітори пептиддеформілази - Google Patents
Інгібітори пептиддеформілази Download PDFInfo
- Publication number
- UA108596C2 UA108596C2 UAA201007153A UAA201007153A UA108596C2 UA 108596 C2 UA108596 C2 UA 108596C2 UA A201007153 A UAA201007153 A UA A201007153A UA A201007153 A UAA201007153 A UA A201007153A UA 108596 C2 UA108596 C2 UA 108596C2
- Authority
- UA
- Ukraine
- Prior art keywords
- cap
- slots
- plate
- slits
- section
- Prior art date
Links
- 239000000081 peptide deformylase inhibitor Substances 0.000 title 1
- 238000009826 distribution Methods 0.000 claims description 8
- 238000005520 cutting process Methods 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- -1 5-fluoro-4-pyrimidinyl Chemical group 0.000 abstract 1
- 108010026809 Peptide deformylase Proteins 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 102000019198 CapZ Actin Capping Protein Human genes 0.000 description 6
- 108010012892 CapZ Actin Capping Protein Proteins 0.000 description 6
- 239000000463 material Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98663107P | 2007-11-09 | 2007-11-09 | |
PCT/US2008/082575 WO2009061879A1 (en) | 2007-11-09 | 2008-11-06 | Peptide deformylase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
UA108596C2 true UA108596C2 (xx) | 2015-05-25 |
Family
ID=40626160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201007153A UA108596C2 (xx) | 2007-11-09 | 2008-06-11 | Інгібітори пептиддеформілази |
Country Status (23)
Country | Link |
---|---|
US (2) | US7893056B2 (ru) |
EP (1) | EP2217226B1 (ru) |
JP (1) | JP5728229B2 (ru) |
KR (2) | KR20160040321A (ru) |
CN (1) | CN101917981B (ru) |
AR (1) | AR069230A1 (ru) |
AU (1) | AU2008323998B2 (ru) |
CA (1) | CA2705246A1 (ru) |
CL (1) | CL2008003326A1 (ru) |
CO (1) | CO6270305A2 (ru) |
CR (1) | CR11483A (ru) |
EA (1) | EA018953B1 (ru) |
ES (1) | ES2549879T3 (ru) |
HK (1) | HK1144070A1 (ru) |
MA (1) | MA31873B1 (ru) |
MX (1) | MX2010005188A (ru) |
NZ (1) | NZ585221A (ru) |
PE (1) | PE20090984A1 (ru) |
PH (1) | PH12013501288A1 (ru) |
TW (2) | TW200934763A (ru) |
UA (1) | UA108596C2 (ru) |
UY (1) | UY31463A1 (ru) |
WO (1) | WO2009061879A1 (ru) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY27813A1 (es) | 2002-05-31 | 2003-12-31 | Smithkline Beecham Corp | Inhibidores de la peptido-desformilasa |
KR101944552B1 (ko) | 2010-09-13 | 2019-01-31 | 오쓰까 세이야꾸 가부시키가이샤 | 세로토닌, 노르에피네프린 또는 도파민의 감소된 신경전달에 의해 야기된 장애의 치료 또는 예방용 헤테로시클릭 화합물 |
UY33939A (es) * | 2011-03-09 | 2012-09-28 | Glaxosmithkline Llc | Inhibidores de la péptido desformilasa |
WO2013058824A1 (en) | 2011-04-07 | 2013-04-25 | Cornell University | Monomers capable of dimerizing in an aqueous solution, and methods of using same |
JP2015500238A (ja) * | 2011-12-02 | 2015-01-05 | グラクソスミスクライン、インテレクチュアル、プロパティー、ナンバー2、リミテッドGlaxosmithkline Intellectual Property No.2 Limited | ペプチドデホルミラーゼ阻害剤 |
LT2788343T (lt) | 2011-12-11 | 2018-06-11 | Viamet Pharmaceuticals (NC), Inc. | Metalo fermentus slopinantys junginiai |
CN102875482A (zh) * | 2012-10-15 | 2013-01-16 | 盛世泰科生物医药技术(苏州)有限公司 | 一种十氢喹喔啉的合成方法 |
WO2014141181A1 (en) | 2013-03-15 | 2014-09-18 | Glaxosmithkline Intellectual Property No 2 Limited | Process for preparing peptide deformylase inhibitors |
TW201620887A (zh) | 2014-01-10 | 2016-06-16 | 葛蘭素史克智慧財產(第二)有限公司 | 化合物及方法 |
US10232037B2 (en) | 2014-02-03 | 2019-03-19 | Brandeis University | Supramolecular hydrogel of fMLF-based molecules and use thereof |
WO2016020784A1 (en) | 2014-08-05 | 2016-02-11 | Pfizer Inc. | N-acylpyrrolidine ether tropomyosin-related kinase inhibitors |
CN104725323A (zh) * | 2014-10-16 | 2015-06-24 | 江苏华益科技有限公司 | 一种2-甲氧基-4-肼基-5-氟嘧啶的合成工艺 |
BR112017010601A2 (pt) | 2014-11-19 | 2017-12-26 | Glaxosmithkline Ip No 2 Ltd | análogos de ureia substituídos em ponte como moduladores de sirtuínas |
WO2017006295A1 (en) | 2015-07-08 | 2017-01-12 | Glaxosmithkline Intellectual Property (No.2) Limited | Hydroxy formamide derivatives and their use |
PL3349586T3 (pl) | 2015-09-18 | 2021-05-31 | Mycovia Pharmaceuticals, Inc. | Sposób wytwarzania związku przeciwgrzybiczego |
ES2921257T3 (es) | 2016-06-20 | 2022-08-22 | Daegu Gyeongbuk Medical Innovation Found | Nuevo derivado de imidazopiridina, procedimiento para prepararlo y composición farmacéutica que contiene el mismo como ingrediente activo para prevenir o tratar el cáncer |
CN113683596B (zh) * | 2021-08-17 | 2023-02-10 | 上海应用技术大学 | 一种嘧啶类端锚聚合酶2抑制剂及其制备方法和应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9223904D0 (en) | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
US6013792A (en) | 1993-08-05 | 2000-01-11 | Syntex (U.S.A.), Inc. | Matrix metalloprotease inhibitors |
US6037472A (en) | 1993-11-04 | 2000-03-14 | Syntex (U.S.A.) Inc. | Matrix metalloprotease inhibitors |
ATE181055T1 (de) | 1994-05-28 | 1999-06-15 | British Biotech Pharm | Succinyl hydroxamsäure-, n-formyl-n-hydroxy- aminocarbonsäure- und succinsäureamid-derivate und ihre verwendung als metalloprotease- inhibitoren |
GB9612884D0 (en) | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
GB9903119D0 (en) | 1999-02-11 | 1999-04-07 | Merck Sharp & Dohme | Therapeutic agents |
US6852752B2 (en) * | 1999-12-17 | 2005-02-08 | Vicuron Pharmaceuticals Inc. | Urea compounds, compositions and methods of use and preparation |
DE10040783A1 (de) | 2000-08-21 | 2002-03-07 | Merck Patent Gmbh | AZA-Aminosäurederivate (Faktor X¶a¶-Inhibitoren 15) |
AR032920A1 (es) | 2001-03-01 | 2003-12-03 | Smithkline Beecham Corp | Compuestos inhibidores de las peptido-deformilasas y medios para tratar infecciones bacterianas utilizando dichos inhibidores |
UY27813A1 (es) | 2002-05-31 | 2003-12-31 | Smithkline Beecham Corp | Inhibidores de la peptido-desformilasa |
GB0228365D0 (en) | 2002-12-05 | 2003-01-08 | British Biotech Pharm | Antibacterial agents |
GB0229673D0 (en) | 2002-12-19 | 2003-01-29 | British Biotech Pharm | Antibacterial agents |
WO2005005456A2 (en) | 2003-07-08 | 2005-01-20 | Glaxo Group Limited | Peptide deformylase inhibitors |
WO2005026146A1 (en) | 2003-09-12 | 2005-03-24 | Warner-Lambert Company Llc | Azetidinyl quinolones as antibacterial agents |
EP1687296A1 (en) | 2003-11-18 | 2006-08-09 | Warner-Lambert Company LLC | Antibacterial aminoquinazolidinedione derivatives |
US7102001B2 (en) | 2003-12-12 | 2006-09-05 | Bristol-Myers Squibb Company | Process for preparing pyrrolotriazine |
ATE437870T1 (de) | 2004-05-12 | 2009-08-15 | Pfizer Prod Inc | Prolinderivate und deren verwendung als dipeptidylpeptidase-iv-inhibitoren |
EP1827449A4 (en) | 2004-11-17 | 2008-01-23 | Smithkline Beecham Corp | USE OF NOVEL ANTIBACTERIAL COMPOUNDS |
GT200600196A (es) | 2005-05-23 | 2007-01-15 | Compuestos n-formil de hidroxilamina | |
US20070197512A1 (en) * | 2006-01-27 | 2007-08-23 | Japan Tobacco Inc. | Carboxylic Acid Compounds and Use Thereof |
-
2008
- 2008-06-11 UA UAA201007153A patent/UA108596C2/uk unknown
- 2008-11-06 JP JP2010533228A patent/JP5728229B2/ja not_active Expired - Fee Related
- 2008-11-06 EA EA201070592A patent/EA018953B1/ru not_active IP Right Cessation
- 2008-11-06 ES ES08847151.1T patent/ES2549879T3/es active Active
- 2008-11-06 CN CN2008801245102A patent/CN101917981B/zh not_active Expired - Fee Related
- 2008-11-06 MX MX2010005188A patent/MX2010005188A/es active IP Right Grant
- 2008-11-06 US US12/265,983 patent/US7893056B2/en not_active Expired - Fee Related
- 2008-11-06 US US12/741,641 patent/US20130045962A1/en not_active Abandoned
- 2008-11-06 CA CA2705246A patent/CA2705246A1/en not_active Abandoned
- 2008-11-06 KR KR1020167008194A patent/KR20160040321A/ko not_active Application Discontinuation
- 2008-11-06 NZ NZ585221A patent/NZ585221A/en not_active IP Right Cessation
- 2008-11-06 KR KR1020107012600A patent/KR20100110774A/ko not_active Application Discontinuation
- 2008-11-06 EP EP08847151.1A patent/EP2217226B1/en active Active
- 2008-11-06 AU AU2008323998A patent/AU2008323998B2/en not_active Ceased
- 2008-11-06 WO PCT/US2008/082575 patent/WO2009061879A1/en active Application Filing
- 2008-11-07 UY UY31463A patent/UY31463A1/es unknown
- 2008-11-07 TW TW097142966A patent/TW200934763A/zh unknown
- 2008-11-07 AR ARP080104885A patent/AR069230A1/es unknown
- 2008-11-07 PE PE2008001898A patent/PE20090984A1/es not_active Application Discontinuation
- 2008-11-07 TW TW103110740A patent/TW201441218A/zh unknown
- 2008-11-07 CL CL2008003326A patent/CL2008003326A1/es unknown
-
2010
- 2010-05-13 CO CO10057587A patent/CO6270305A2/es active IP Right Grant
- 2010-05-31 MA MA32881A patent/MA31873B1/fr unknown
- 2010-06-09 CR CR11483A patent/CR11483A/es not_active Application Discontinuation
- 2010-11-15 HK HK10110601.8A patent/HK1144070A1/zh not_active IP Right Cessation
-
2013
- 2013-06-18 PH PH12013501288A patent/PH12013501288A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PH12013501288A1 (en) | 2015-02-09 |
CA2705246A1 (en) | 2009-05-14 |
HK1144070A1 (zh) | 2011-01-28 |
KR20160040321A (ko) | 2016-04-12 |
UY31463A1 (es) | 2009-05-29 |
KR20100110774A (ko) | 2010-10-13 |
EA201070592A1 (ru) | 2010-12-30 |
JP2011503092A (ja) | 2011-01-27 |
CO6270305A2 (es) | 2011-04-20 |
PE20090984A1 (es) | 2009-08-07 |
ES2549879T3 (es) | 2015-11-02 |
AU2008323998B2 (en) | 2013-01-10 |
EA018953B1 (ru) | 2013-12-30 |
CR11483A (es) | 2010-09-21 |
MX2010005188A (es) | 2010-05-27 |
TW201441218A (zh) | 2014-11-01 |
CL2008003326A1 (es) | 2010-03-05 |
AU2008323998A1 (en) | 2009-05-14 |
US20130045962A1 (en) | 2013-02-21 |
EP2217226A4 (en) | 2012-03-21 |
MA31873B1 (fr) | 2010-11-01 |
EP2217226A1 (en) | 2010-08-18 |
EP2217226B1 (en) | 2015-07-22 |
JP5728229B2 (ja) | 2015-06-03 |
TW200934763A (en) | 2009-08-16 |
AR069230A1 (es) | 2010-01-06 |
CN101917981B (zh) | 2012-11-14 |
US7893056B2 (en) | 2011-02-22 |
US20090306066A1 (en) | 2009-12-10 |
NZ585221A (en) | 2012-05-25 |
WO2009061879A1 (en) | 2009-05-14 |
CN101917981A (zh) | 2010-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA108596C2 (xx) | Інгібітори пептиддеформілази | |
ES2630115T3 (es) | Derivados de 5-fluoro-n-(piridin-2-il)piridin-2-amina con sulfoximina sustituida y su uso como inhibidores de quinasa cdk9 | |
HRP20170634T4 (hr) | Kristalni oblik od 4-metil-n-[3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamida | |
RS51216B (sr) | KRISTALNI OBLIK-HLORO-4-(ß-D-GLUKOPIRANOZ-1-IL) -2 - [4-((S)-TETRAHIDROFURAN-3-ILOKSI)-BENZIL]-BENZOLA, POSTUPAK ZA NJEGOVO DOBIJANJE I NJEGOVA PRIMENA ZA DOBIJANJE LEKOVA | |
EA200870299A1 (ru) | Гербицидные изоксазольные соединения | |
HRP20131051T1 (hr) | Inhibitori proteinskih kinaza | |
MX2009004900A (es) | Arilamidas sustituidas por tiazol u oxazol. | |
RU2014107329A (ru) | Башня мокрого тушения для тушения горячего кокса | |
GEP20135767B (en) | Fungicidal compositions | |
AR105483A1 (es) | Sal de fumarato cristalina de (s)-[3,4-difluoro-2-(2-fluoro-4-yodofenilamino)fenil][3-hidroxi-3-(piperidin-2-il)azetidin-1-il]-metanona | |
HRP20141196T1 (hr) | Anhidrirani kristalni oblik orvepitant-maleata | |
AR066158A1 (es) | COMPUESTO DE PIRIDAZINA CRISTALINA, UN MÉTODO PARA SU ELABORACIoN Y UNA COMPOSICIoN QUE LO COMPRENDE. | |
RU2012112491A (ru) | Усовершенствованный аппарат для отделения капель жидкости, увлекаемых газом или паром | |
HRP20150356T1 (hr) | Kristalni oblici soli prasugrela | |
FR2905948B1 (fr) | Procede de fabrication d'amines par hydrogenation de composes nitriles | |
CN208975197U (zh) | 一种新型精馏提纯装置 | |
RU2012146440A (ru) | Реактор для проведения газожидкостных двухфазных реакций | |
RU2010148909A (ru) | Устройство для рефлексотерапии | |
Soleimani et al. | Some formulas for the polynomials and topological indices of nanostructures | |
BR112012018626A8 (pt) | novo polimorfo de cloridrato de éster de (4-hdiroxicarbamoil-fenil)-ácido carbâmico (6-dimetilamino metil-2-naftalenil) | |
MA50869A (fr) | Procédé d'obtention d'un fertilisant liquide à partir de biomasse végétale | |
CO5540317A2 (es) | Derivados de 4-(fenil-(piperidin-4-il)-amino)-benzamida y sus usos para el tratamiento del dolor, la ansiedad o desordenes gastrointestinales | |
UA134267U (uk) | Контактна тарілка масообмінного апарата | |
RU2343677C2 (ru) | Вибрационный высевающий аппарат | |
UA126202U (uk) | Елемент насадки масообмінного апарата |